Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Leukemia Research|February 4, 2019
A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1<sup>T315I</sup> in Ph+ CMLKaroline V Gleixner, Irina Sadovnik, Mathias Schneeweiss, et al.Blood|April 19, 2003
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated diseaseThomas Lion, Rosi Baumgartinger, Franz Watzinger, et al.Experimental Hematology|January 11, 2014
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRAIrina Sadovnik, Els Lierman, Barbara Peter, et al.Haematologica|April 5, 2007
Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patientKaan Boztug, Ulrich Baumann, Matthias Ballmaier, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 17, 2004
Rapid determination of Epstein-Barr virus latent or lytic infection in single human cells using in situ hybridizationElena E Leenman, Renate E Panzer-Grümayer, Susanna Fischer, et al.Peerj|November 16, 2020
Polylactic acid as a suitable material for 3D printing of protective masks in times of COVID-19 pandemicEva Vaňková, Petra Kašparová, Josef Khun, et al.Hematological Oncology|August 4, 2018
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasmsTariq I Mughal, Thomas Lion, Omar Abdel-Wahab, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantationRené Geyeregger, Christine Freimüller, Julia Stemberger, et al.Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.The Journal of Steroid Biochemistry and Molecular Biology|August 14, 2016
Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cellsFranz J J Rieder, Charlotte Gröschel, Marie-Theres Kastner, et al.Pageof 10